• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.65% Nasdaq Up1.83%

    More On 3933.HK

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    The United Laboratories International Holdings Limited (3933.HK)

    -HKSE
    4.74 Up 0.06(1.28%) 2:59AM EST
    Add to Portfolio
    ProfileGet Profile for:
    The United Laboratories International Holdings Limited
    6 Fuk Wang Street
    Yuen Long Industrial Estate
    Yuen Long,
    Hong Kong - Map
    Website: http://www.tul.com.cn

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:12,000

    Business Summary 

    The United Laboratories International Holdings Limited, an investment holding company, manufactures and sells pharmaceutical products. The company operates in three segments: Intermediate Products, Bulk Medicine, and Finished Products. It offers antibiotic and non-antibiotic finished products, and soft capsules casings. The company also produces and sells bulk medicine, pharmaceutical intermediate products, and organic fertilizers. In addition, it is engaged in trading pharmaceutical products. It operates primarily in the People's Republic of China, Europe, India, Hong Kong, the Middle East, South America, and other Asian regions. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong. The United Laboratories International Holdings Limited is a subsidiary of Heren Far East Limited.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on The United Laboratories International Holdings Limited

    Key Executives 
     PayExercised
    Mr. Hoi Shan Tsoi , 36
    Exec. Chairman
    3.30MN/A
    Mr. Wing Hon Leung CPA, 52
    Vice Chairman, Chief Financial Officer, Qualified Accountant and Company Sec.
    3.74MN/A
    Ms. Su Yan Zhu , 49
    VP and Exec. Director
    3.70MN/A
    Ms. Xian Hong Zou , 49
    VP and Exec. Director
    3.64MN/A
    Ms. Siu Chit Choy , 41
    Global Director of Intermediate & Bulk Medicine for The Group and Exec. Director
    1.89MN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in HKD.